Tomarce, Reyna Mae .

HRN: 11-92-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFUROXIME 750MG (VIAL)
06/18/2022
06/25/2022
IV
750 Mg
Q8hrs
PCAP C
Waiting Final Action 
06/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/18/2022
06/25/2022
IV
2 Grams
Q6H
PCAP D
06/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/18/2022
06/25/2022
IV
100 Mg
Q24
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: